SCN8A Developmental and Epileptic Encephalopathy Syndrome
Neurology·MeSH: Epilepsy
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| nbi-921352 | NEUROCRINE BIOSCIENCES INC (NBIX) |
Frequently asked questions
How many drugs are in development for SCN8A Developmental and Epileptic Encephalopathy Syndrome?
BioSniper tracks 1 drug in development for SCN8A Developmental and Epileptic Encephalopathy Syndrome across 1 company.
How many clinical trials target SCN8A Developmental and Epileptic Encephalopathy Syndrome?
There are 2 clinical trials targeting SCN8A Developmental and Epileptic Encephalopathy Syndrome tracked by BioSniper.
Deep-dive into SCN8A Developmental and Epileptic Encephalopathy Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis